Large-scale virtual screening has become a valuable tool for early-phase drug discovery. Recent expansions of commercial chemical space have made it computationally intractable to evaluate all
The emergence of new viral infections and drug-resistant bacteria urgently necessitates expedient therapeutic development. Repurposing and redesign of existing drugs against different targets are one
